 |
|
β-Blockade in Noncardiac SurgeryOutcome at All Levels of Cardiac Risk
Haytham M. A. Kaafarani, MD;
Prasad V. Atluri, MD;
John Thornby, PhD;
Kamal M. F. Itani, MD
Arch Surg. 2008;143(10):940-944.
Hypothesis We hypothesized that the relationship among β-blocker use, heart rate control, and perioperative cardiovascular outcome would be similar in patients at all levels of cardiac risk.
Design Retrospective cohort study.
Setting Michael E. DeBakey Veterans Affairs Medical Center, Houston, Texas.
Patients Among all patients who underwent various noncardiac surgical procedures in 2000, those who received perioperative β-blockers were matched and compared with a control group from the same patient population.
Main Outcome Measures Thirty-day stroke, cardiac arrest, myocardial infarction, and mortality, as well as mortality at 1 year.
Results Patients at all levels of cardiac risk who received β-blockers had lower preoperative and intraoperative heart rates. The β-blocker group had higher rates of 30-day myocardial infarction (2.94% vs 0.74%, P =.03) and 30-day mortality (2.52% vs 0.25%, P =.007) compared with the control group. In the β-blocker group, patients who died perioperatively had significantly higher preoperative heart rate (86 vs 70 beats/min, P =.03). None of the deaths occurred among the patients at high cardiac risk.
Conclusion Among patients at all levels of cardiac risk undergoing noncardiac surgery, administration of β-blockers should achieve adequate heart rate control and should be carefully monitored in patients who are not at high cardiac risk.
Author Affiliations: Department of Surgery, University of South Florida, Tampa (Dr Kaafarani); Department of Surgery, Veterans Affairs Boston Health Care System, West Roxbury, and Boston University and Harvard Medical School, Boston, Massachusetts (Drs Kaafarani and Itani); and Department of Anesthesia, Baylor College of Medicine (Dr Atluri), and Biostatistical Laboratory, Michael E. DeBakey Veterans Affairs Medical Center (Dr Thornby), Houston, Texas.
 CiteULike  Connotea  Delicious  Digg  Facebook  Reddit  Technorati  Twitter
What's this?
RELATED ARTICLE
β-Blockade in Noncardiac Surgery—Invited Critique
Todd E. Rasmussen
Arch Surg. 2008;143(10):944.
EXTRACT
| FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
2009 ACCF/AHA Focused Update on Perioperative Beta Blockade Incorporated Into the ACC/AHA 2007 Guidelines on Perioperative Cardiovascular Evaluation and Care for Noncardiac Surgery
American College of Cardiology Foundation et al.
J Am Coll Cardiol 2009;54:e13-e118.
FULL TEXT
2009 ACCF/AHA Focused Update on Perioperative Beta Blockade
American College of Cardiology Foundation et al.
J Am Coll Cardiol 2009;54:2102-2128.
FULL TEXT
2009 ACCF/AHA Focused Update on Perioperative Beta Blockade: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines
2009 WRITING GROUP TO REVIEW NEW EVIDENCE AND UPDA et al.
Circulation 2009;120:2123-2151.
FULL TEXT
2009 ACCF/AHA Focused Update on Perioperative Beta Blockade Incorporated Into the ACC/AHA 2007 Guidelines on Perioperative Cardiovascular Evaluation and Care for Noncardiac Surgery: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines
2007 WRITING COMMITTEE MEMBERS et al.
Circulation 2009;120:e169-e276.
FULL TEXT
Cardiovascular Evaluation and Management of Severely Obese Patients Undergoing Surgery: A Science Advisory From the American Heart Association
Poirier et al.
Circulation 2009;120:86-95.
ABSTRACT
| FULL TEXT
Beta-Blockers: Must We Throw the Baby Out with the Bath Water?
Stone et al.
Anesth. Analg. 2009;108:1987-1990.
FULL TEXT
Chapter 3 Patient selection and preparation for day surgical procedures
Jakobsson
OAL Anaesthesia for Day Case Surgery 2009;1:med-9780199577132-chapter-med-9780199577132-chapter.
ABSTRACT
| FULL TEXT
More Evidence That Perioperative {beta}-Blockers in Noncardiac Surgery Can Be Harmful
Journal Watch Hospital Medicine 2008;2008:1-1.
FULL TEXT
|
